Publications
Publications
Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
Partnership expanded to include vascular trauma repair outside of the United States. Fresenius Medical Care is a leading participant in fully committed PIPE financing transaction. Durham, N.C. – June 11, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing
June 11, 2021
No Comments
Humacyte to Provide Investor Update on June 7
Durham, N.C. – June 4, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced an investor update presentation will be available at 9:00 a.m. ET on Monday, June 7
June 4, 2021
No Comments
“Patency of ePTFE Arteriovenous Graft Placements in Hemodialysis Patients: Systematic Literature Review and Meta-analysis”
Article excerpt would be here.
June 3, 2021
No Comments
March 11, 1021